Johnson & Johnson (JNJ) vs Pfizer Inc. (PFE)
A side-by-side comparison of Johnson & Johnson and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
JNJ
Johnson & Johnson
$266.73HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
Total return — JNJ vs PFE
growth of $100 · dividends reinvested · last 30yJNJ +2166.3%PFE +543.3%JNJ compounded faster
JNJ PFE
JNJ vs PFE: by the numbers
- •JNJ is the larger company ($642.79B vs $143.91B market cap).
- •PFE trades at the lower trailing earnings multiple (18.83 vs 30.82 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 2.93% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 1.97%).
Metrics side by side
Valuation
| Metric | JNJ | PFE |
|---|---|---|
| P/E ratio | 30.82 | 18.83 |
| Forward P/E | 22.76 | 8.38 |
| P/S ratio | 6.63 | 2.23 |
| P/B ratio | 7.64 | 1.57 |
| PEG ratio | 0.21 | N/A |
| EV / EBITDA | 19.98 | 9.72 |
| FCF yield | 3.48% | 6.71% |
Profitability
| Metric | JNJ | PFE |
|---|---|---|
| Gross margin | 70.45% | 69.35% |
| Operating margin | 26.81% | 23.45% |
| Net margin | 21.48% | 11.83% |
| ROE | 24.76% | 8.31% |
| ROIC | 13.71% | 8.84% |
Dividends
| Metric | JNJ | PFE |
|---|---|---|
| Dividend yield | 1.97% | 6.97% |
| Payout ratio | 47.51% | 126.47% |
Growth (annualized)
| Metric | JNJ | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 2.93% | 8.22% |
| EPS CAGR (5Y) | 11.51% | -3.78% |
| FCF CAGR (5Y) | -0.49% | -3.79% |
| Total return CAGR (5Y) | 12.13% | -5.21% |
Frequently asked
- Which has the lower trailing P/E, JNJ or PFE?
- PFE has the lower trailing P/E: JNJ trades at 30.82 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, JNJ or PFE?
- Over the past five years, PFE grew revenue faster — JNJ at a 2.93% CAGR versus PFE at 8.22%.
- Does JNJ or PFE pay a bigger dividend?
- JNJ yields 1.97% and PFE yields 6.97% based on trailing dividends and the latest price.
- Is JNJ or PFE more profitable?
- JNJ runs the higher net margin — JNJ at 21.48% versus PFE at 11.83%.
- How have JNJ and PFE total returns compared?
- Over the past 10 years, JNJ delivered 10.85% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Johnson & Johnson P/E ratioPfizer P/E ratioJohnson & Johnson dividend yieldPfizer dividend yieldJohnson & Johnson ROEPfizer ROEJohnson & Johnson operating marginPfizer operating marginJohnson & Johnson revenue growthPfizer revenue growthJohnson & Johnson free cash flowPfizer free cash flow
Johnson & Johnson & Pfizer appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersHighest FCF Yield StocksLargest Companies by Market Cap
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.